Cell Isolation Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The cell isolation market size has grown rapidly in recent years. It will grow from $4.65 billion in 2024 to $5.25 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to regulatory support and guidelines, adoption of single-cell analysis, expansion of biopharmaceutical industry, growth of stem cell research, escalating aging population.

The cell isolation market size is expected to see rapid growth in the next few years. It will grow to $8.4 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to rising demand for cell-based assays, adoption of microfluidics-based technologies, increasing funding for life sciences research, expansion of biopharmaceutical industry, expanding research in areas like cancer and regenerative medicine. Major trends in the forecast period include automation and robotics integration, multiplexed cell isolation, integration of artificial intelligence (AI), single-cell isolation and analysis, miniaturization and portability.

The trajectory of the cell isolation market is set to be influenced by the increasing prevalence of chronic diseases. Chronic illnesses, characterized by their long-term nature, necessitate comprehensive strategies involving public health interventions, lifestyle policies, healthcare infrastructure enhancements, and heightened awareness. This prevalence fuels advancements in cell isolation technologies, unlocking opportunities in stem cell research for regenerative medicine and diverse health treatments. For instance, data from May 2023 released by the Centers for Disease Control and Prevention (CDC.gov) reveals a notable increase in heart disease and cancer deaths in 2022 compared to the previous year, emphasizing the driving force of chronic diseases in shaping the cell isolation market.

Innovative technological strides, such as the closed cell isolation system, are at the forefront of strategies employed by major players in the cell isolation market. These advancements target improved cell purity, workflow efficiency, and therapeutic application efficacy. The closed cell isolation system segregates specific cell populations from heterogeneous samples such as blood or tissue with minimal contamination and optimal cell viability. For example, Sony Corporation's January 2022 launch of the CGX10 closed cell isolation system underscores a paradigm shift beyond research applications into the realm of cell therapy and regenerative medicine. Facilitating the creation of Good Manufacturing Practice (GMP)-compliant manufacturing processes, this innovation amplifies Sony's contribution to advancing cell therapy endeavors.

In June 2022, Bio-Techne Corporation, a life sciences and clinical diagnostics company based in the United States, acquired Namocell Inc. for an undisclosed sum. Through this acquisition, Bio-Techne intends to broaden its offerings in single-cell technology, strengthen its expertise in cell and gene therapy research, and support applications in drug discovery and development. Namocell Inc., also a US-based company, focuses on single-cell isolation and analysis technology.

Major companies operating in the cell isolation market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merk Co. & KGaA, GE Healthcare Company, Becton Dickinson & Company, Corning Inc., Lonza Inc., Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc., Sartorius AG, Terumo Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, STEMCELL Technologies Inc., Cytek Biosciences Inc., Miltenyi Biotec Inc., Neogenomics Laboratories Inc., Promega Corporation, Takara Bio Inc., Molecular Devices LLC, NanoString Technologies Inc., Proteintech Group Inc., Sony Biotechnology Inc., PluriSelect Life Science UG & Co. KG, Invent Biotechnologies Inc., Akadeum Life Sciences Inc.

North America was the largest region in the cell isolation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell isolation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell isolation market consists of revenues earned by entities by providing services such as cell sorting services, cell separation services, and cell purification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell isolation market also includes sales of dielectrophoresis (DEP) devices, automated liquid handling systems, microfluidic devices, and immunomagnetic separators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Cell isolation is the technique used to extract individual living cells from either a solid tissue block or a suspension of cells. It plays a crucial role in various research fields, including stem cell research, oncology studies, and clinical diagnostics. By targeting specific characteristics such as size, charge, density, shape, or protein expression, cell isolation enables the separation of distinct cell populations from heterogeneous samples. This process is essential for obtaining pure cell populations for further analysis and experimentation.

The primary product categories are consumables and instruments. Consumables play a critical role in enhancing cell growth, productivity, health, and viability, while also reducing the risk of contamination, improving result reproducibility, and minimizing costs. Cell types are broadly categorized into human cells and animal cells, derived from various sources such as bone marrow, adipose tissues, cord blood, and embryonic stem cells. These cells find application across diverse fields including biomolecule isolation, cancer research, stem cell research, tissue regeneration, in-vitro diagnostics, and more. End-users of cell isolation products include pharmaceutical and biotechnology companies, research institutes, academic institutions, hospitals, diagnostic laboratories, and other relevant entities.

The cell isolation market research report is one of a series of new reports that provides cell isolation market statistics, including cell isolation industry global market size, regional shares, competitors with a cell isolation market share, detailed cell isolation market segments, market trends and opportunities, and any further data you may need to thrive in the cell isolation industry. This cell isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.